Rapport Therapeutics, Inc. (RAPP) Free cash flow 2023–2025
Rapport Therapeutics, Inc. (RAPP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$88.1MFY2025 · since FY2023: -$28.8M → -$88.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.1M | -31.0% |
| FY2024 | -$67.2M | -133.3% |
| FY2023 | -$28.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice